Gatehouse Bio is a bio-data company in collaboration with AstraZeneca for the identification of new targets for respiratory and cardiovascular diseases using Gatehouse Bio’s AI-powered platform. The sRNAlytics platform identifies small RNA (sRNA) signatures in sequencing data and points to molecular pathways that correlate to or potentially drive disease.
Timeline
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
References
3
Type: Web page
https://gatehousebio.com/about-us/4
Type: Web page
https://gatehousebio.com/about-us/5
Type: Web page
https://gatehousebio.com/about-us/6
Type: Web page
https://gatehousebio.com/contact-us/